_ich-q3a-amp-ich-q3b-ii-specification-of-impurities-ii-pharma-guidelines-ii-rishabh-ii-interview-preview-1.jpg "ICH Q3A & ICH Q3B II Specification of Impurities II Pharma guidelines II Rishabh II Interview from q3a ich guideline Video Screenshot Preview 1")
Gallery_ich-q3a-amp-ich-q3b-ii-specification-of-impurities-ii-pharma-guidelines-ii-rishabh-ii-interview-preview-3.jpg "ICH Q3A & ICH Q3B II Specification of Impurities II Pharma guidelines II Rishabh II Interview from q3a ich guideline Video Screenshot Preview 3")
Gallery_ich-q3a-amp-ich-q3b-ii-specification-of-impurities-ii-pharma-guidelines-ii-rishabh-ii-interview-preview-hqdefault.jpg "ICH Q3A & ICH Q3B II Specification of Impurities II Pharma guidelines II Rishabh II Interview from q3a ich guideline Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 19 minutes 19 seconds
👁 View: 4.1K times
Play Audio:👁 View: 4.1K times
Description:
Rishabh Jain Pharma
Rishabh Jain Pharma
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_quality-q3ar2.webp "BIO TUBE")
_ich-q3a-r2-pharmababavikki.webp "VIKRAM PHARMABABA")
_identified-impurityunidentified-impurity-specified-impurity-unspecified-impurity-as-per-ich-q3a.webp "Pharma Pill")
⏲ 7 minutes 27 seconds 👁 13.3K
_ich-guidelines.webp "Points of Pharma")
_analytical-method-validation.webp "Hitendrakumar Shah")
_ich-q2r1-analytical-method-validation.webp "Pharma Pill")
_how-to-define-limit-for-mutagenic-impurity-in-drug-product.webp "Pharma Growth Hub")
_new-approaches-for-an-integrated-nonclinical-clinical-qt-proarrhythmic-risk-assessment-1-of-2.webp "U.S. Food and Drug Administration")
⏲ 2 hours 19 minutes 9 seconds 👁 4K
_quality-q3ar2.jpg)
_ich-q3a-r2-pharmababavikki.jpg)
_identified-impurityunidentified-impurity-specified-impurity-unspecified-impurity-as-per-ich-q3a.jpg)
_ich-guidelines.jpg)
_analytical-method-validation.jpg)
_ich-q2r1-analytical-method-validation.jpg)
_how-to-define-limit-for-mutagenic-impurity-in-drug-product.jpg)
_new-approaches-for-an-integrated-nonclinical-clinical-qt-proarrhythmic-risk-assessment-1-of-2.jpg)
![[+]](/images/menu.gif){kind=small}